Hers is the sister platform for women, operating under the same Hims & Hers Health umbrella
its absence is informative but not disqualifying, especially when mechanistic and physiological evidence is otherwise robust (Nelson et al., 2015)
This approach, originally proposed by Professor Ernest Starling in the early 1900s, initially focused on gut hormones but was overshadowed by discoveries in insulin and leptin [14]
This context may help your provider assess whether GLP-1 treatment aligns with your biology, though genetics does not predict exact medication response
This incretin hormone also delays gastric emptying, thereby slowing glucose absorption and preventing sharp rises in insulin levels
Chronic GCGR activation should increase plasma glucose levels and insulin levels would then need to rise to promote normoglycaemia during tri-agonist treatment, but this is not the case